From: The EEF1A2 gene expression as risk predictor in localized prostate cancer
Parameter | n |
---|---|
Patients with PCa | 59 (mean age 62.9 ± 6.9) |
T stage | |
T1 | – |
T2 | 23 |
T3 | 33 |
T4 | 3 |
N stage | |
N1 | 5 |
N0 | 47 |
Nx | 7 |
Gleason score | |
3 | 1 |
4 | 0 |
5 | 10 |
6 | 15 |
7a | 15 |
7b | 4 |
8 | 5 |
9 | 3 |
10 | 2 |
n.a. due to prior antihormonal therapy | 4 |
average serum PSA level | 13.3 ng/ml (2.8–73.0 ng/ml) |
Control patients | 15 (mean age 67.2 ± 11.3) |